Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 51 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (28)
P 1 (1)
P 2 (2)
P 3 (1)
P 4 (2)

Trial Status

Recruiting21
Not Yet Recruiting14
Completed8
Enrolling By Invitation5
Active Not Recruiting2
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT07569198Phase 2Recruiting

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

NCT07733297Not ApplicableCompletedPrimary

The Effect of Cognitive Behavioral Psychoeducation on Internalized Stigma in Individuals With Bipolar Disorder

NCT07732933Not ApplicableNot Yet RecruitingPrimary

Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models

NCT07680153Phase 4Not Yet RecruitingPrimary

Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

NCT07664852Phase 3Not Yet RecruitingPrimary

Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression

NCT07434414CompletedPrimary

LRFN5 and OLFM4 in Bipolar Disorder

NCT07337889Not ApplicableRecruiting

Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder

NCT07211217Not ApplicableRecruitingPrimary

Time Restricted Eating (TRE) in Bipolar Disorder

NCT07632989Not ApplicableActive Not RecruitingPrimary

Virtual Reality-Based Cognitive Remediation in Schizophrenia and Bipolar Disorder

NCT07622927RecruitingPrimary

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

NCT07619092Not ApplicableRecruiting

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

NCT07589647Not ApplicableRecruitingPrimary

Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity

NCT07586150Not ApplicableNot Yet Recruiting

Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)

NCT07573839RecruitingPrimary

An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature Fusion

NCT07556692Not ApplicableRecruitingPrimary

A Study of Home-use Brain Stimulation to Treat Bipolar Depression

NCT06920940Not ApplicableRecruitingPrimary

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

NCT07130500Not ApplicableEnrolling By Invitation

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

NCT07445802Not ApplicableNot Yet Recruiting

Medication Adherence in Severe Mental Illness: a Promotion Program

NCT06488573Not ApplicableRecruiting

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

NCT07427966Not Yet Recruiting

Psychobiological Markers to Improve Diagnosis and to Predict Affective Episodes in Bipolar Disorder

Scroll to load more

Research Network

Activity Timeline